Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2.5 Mg Versus 5 Mg for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients Receiving High-dose Melphalan Conditioning: the FONDO-LOW Study
Latest Information Update: 27 Sep 2024
At a glance
- Drugs Olanzapine (Primary) ; Dexamethasone; Fosaprepitant; Ondansetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- Acronyms FONDO-LOW
- 27 Sep 2024 New trial record